Protagonist Therapeutics (PTGX) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to $2.2 million.
- Protagonist Therapeutics' Other Gross PP&E Adjustments rose 19410.52% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 19410.52%. This contributed to the annual value of $190000.0 for FY2024, which is 9674.82% down from last year.
- Per Protagonist Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at $2.2 million for Q3 2025, which was up 19410.52% from $2.4 million recorded in Q2 2025.
- Protagonist Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $5.8 million during Q4 2023, with a 5-year trough of -$5.4 million in Q3 2021.
- In the last 5 years, Protagonist Therapeutics' Other Gross PP&E Adjustments had a median value of $1.7 million in 2024 and averaged $824421.1.
- As far as peak fluctuations go, Protagonist Therapeutics' Other Gross PP&E Adjustments surged by 75336.79% in 2022, and later crashed by 16303.02% in 2024.
- Over the past 5 years, Protagonist Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $386000.0 in 2021, then skyrocketed by 753.37% to $3.3 million in 2022, then surged by 77.38% to $5.8 million in 2023, then crashed by 96.75% to $190000.0 in 2024, then soared by 1067.89% to $2.2 million in 2025.
- Its Other Gross PP&E Adjustments was $2.2 million in Q3 2025, compared to $2.4 million in Q2 2025 and $1.0 million in Q1 2025.